SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1435.2

(13.02%)

Net Income Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual net income in 2023 was 90.92 Million INR , down -20.68% from previous year.
SMS Lifesciences India Limited's latest quarterly net income in 2024 Q1 was 69.98 Million INR , up 18.53% from previous quarter.
SMS Lifesciences India Limited reported an annual net income of 114.62 Million INR in 2022, down -54.73% from previous year.
SMS Lifesciences India Limited reported an annual net income of 253.22 Million INR in 2021, up 86.79% from previous year.
SMS Lifesciences India Limited reported a quarterly net income of 43.04 Million INR for 2023 Q3, up 545.96% from previous quarter.
SMS Lifesciences India Limited reported a quarterly net income of 6.66 Million INR for 2023 Q2, up 137.12% from previous quarter.

Annual Net Income Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Net Income of SMS Lifesciences India Limited (2023 - 2015)

Year	Net Income	Net Income Growth
2023	90.92 Million INR	-20.68%
2022	114.62 Million INR	-54.73%
2021	253.22 Million INR	86.79%
2020	135.56 Million INR	33.13%
2019	101.83 Million INR	-42.94%
2018	178.47 Million INR	174.52%
2017	65.01 Million INR	-48.6%
2016	126.47 Million INR	683739.47%
2015	-18.5 Thousand INR	0.0%

Year	Net Income	Net Income Growth
2024 Q1	69.98 Million INR	18.53%
2023 Q3	43.04 Million INR	545.96%
2023 Q2	6.66 Million INR	137.12%
2023 Q1	-17.95 Million INR	-204.57%
2023 Q4	59.04 Million INR	37.18%
2023 FY	90.92 Million INR	-20.68%
2022 Q2	27.51 Million INR	-8.54%
2022 FY	114.62 Million INR	-54.73%
2022 Q4	17.16 Million INR	-56.95%
2022 Q1	30.08 Million INR	-66.99%
2022 Q3	39.87 Million INR	44.91%
2021 Q4	91.12 Million INR	291.26%
2021 Q3	23.29 Million INR	-77.28%
2021 Q1	36.27 Million INR	-28.22%
2021 FY	253.22 Million INR	86.79%
2021 Q2	102.52 Million INR	182.62%
2020 Q1	24.82 Million INR	19.26%
2020 FY	135.56 Million INR	33.13%
2020 Q4	50.53 Million INR	87.48%
2020 Q3	26.95 Million INR	-18.69%
2020 Q2	33.14 Million INR	33.53%
2019 Q2	36.81 Million INR	-17.62%
2019 FY	101.83 Million INR	-42.94%
2019 Q4	20.81 Million INR	713.71%
2019 Q3	-3.39 Million INR	-109.21%
2019 Q1	44.68 Million INR	-15.07%
2018 Q3	51.03 Million INR	15.7%
2018 FY	178.47 Million INR	174.52%
2018 Q4	52.61 Million INR	3.11%
2018 Q1	30.71 Million INR	55.8%
2018 Q2	44.1 Million INR	43.6%
2017 FY	65.01 Million INR	-48.6%
2017 Q4	19.71 Million INR	-20.37%
2017 Q1	10.38 Million INR	-64.98%
2017 Q2	10.15 Million INR	-2.14%
2017 Q3	24.75 Million INR	143.71%
2016 Q1	46.9 Million INR	0.0%
2016 Q2	17.5 Million INR	-62.67%
2016 FY	126.47 Million INR	683739.47%
2016 Q3	43.37 Million INR	147.74%
2016 Q4	29.64 Million INR	-31.67%
2015 FY	-18.5 Thousand INR	0.0%

Peer Net Income Comparison of SMS Lifesciences India Limited

Name	Net Income	Net Income Difference
Biocon Limited	10.22 Billion INR	99.111%
Blue Jet Healthcare Limited	1.63 Billion INR	94.447%
Concord Biotech Limited	3.08 Billion INR	97.049%
Dishman Carbogen Amcis Limited	-1.53 Billion INR	105.926%
Jubilant Ingrevia Limited	1.82 Billion INR	95.028%
Lyka Labs Limited	-24.89 Million INR	465.261%
Panacea Biotec Limited	-11.73 Million INR	875.175%
Piramal Pharma Limited	178.2 Million INR	48.974%
Supriya Lifescience Limited	1.19 Billion INR	92.366%
Syngene International Limited	5.1 Billion INR	98.217%
TAKE Solutions Limited	-1.19 Billion INR	107.601%
Zota Health Care Limited	-143.47 Million INR	163.374%